Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 31/08/23 → 30/08/25 |
Keywords
- Clinical trial
- RIN-PF-302
Clinical Trial Phase
- Phase III (a & b)
An Open-label Extension Study of Inhaled Treprostinil in Subjects with Fibrotic Lung Disease
- Glaspole, Ian (Primary Chief Investigator (PCI))
- Symons, Karen (Project Manager)
Project: Research